These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9859912

  • 1. Ascomycins in dermatology.
    Paul C, Ho VC.
    Semin Cutan Med Surg; 1998 Dec; 17(4):256-9. PubMed ID: 9859912
    [Abstract] [Full Text] [Related]

  • 2. Ascomycins: promising agents for the treatment of inflammatory skin diseases.
    Paul C, Graeber M, Stuetz A.
    Expert Opin Investig Drugs; 2000 Jan; 9(1):69-77. PubMed ID: 11060661
    [Abstract] [Full Text] [Related]

  • 3. Pimecrolimus: a review.
    Gupta AK, Chow M.
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):493-503. PubMed ID: 12941081
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology.
    Meingassner JG, Grassberger M, Fahrngruber H, Moore HD, Schuurman H, Stütz A.
    Br J Dermatol; 1997 Oct; 137(4):568-76. PubMed ID: 9390333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG.
    Int Arch Allergy Immunol; 2006 Oct; 141(3):199-212. PubMed ID: 16926539
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Macrolide immunosuppressants.
    Mrowietz U.
    Eur J Dermatol; 1999 Oct; 9(5):346-51. PubMed ID: 10417434
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E, Burgdorf WH, Wollenberg A.
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [Abstract] [Full Text] [Related]

  • 17. Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.
    Stuetz A, Grassberger M, Meingassner JG.
    Semin Cutan Med Surg; 2001 Dec; 20(4):233-41. PubMed ID: 11770910
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.
    Simpson D, Noble S.
    Drugs; 2005 Dec; 65(6):827-58. PubMed ID: 15819596
    [Abstract] [Full Text] [Related]

  • 20. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.
    Bornhövd EC, Burgdorf WH, Wollenberg A.
    Curr Opin Investig Drugs; 2002 May; 3(5):708-12. PubMed ID: 12090543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.